Found: 6
Select item for more details and to access through your institution.
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first-line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1433, doi. 10.3892/ijo.2019.4709
- By:
- Publication type:
- Article
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.744085
- By:
- Publication type:
- Article
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA).
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1515, doi. 10.3390/cancers16081515
- By:
- Publication type:
- Article
Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08627-8
- By:
- Publication type:
- Article
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2400, doi. 10.3390/jcm9082400
- By:
- Publication type:
- Article